
More than half of Germany's medium-sized companies expect an economic downturn next year, according to a survey by the BVMW business association.
Christoph Ahlhaus, the association's chief executive, said on Saturday that "superficial reforms are no longer enough to get Germany back on track."
He said businesses expect the federal government to finally deliver on long-promised structural reforms and concrete relief measures in areas such as bureaucracy, the labour market, taxation and energy costs.
According to the survey, 54% of companies expect an economic slowdown, while only 22% anticipate an upswing. In addition, 42% of respondents said they plan to scale back investment in 2026, the association said.
Medium-sized companies, known as the Mittelstand, form the backbone of Germany's economy and account for a large share of employment and investment.
The German economy contracted in 2023 and 2024, while growth is forecast to be minimal this year and no meaningful recovery is expected in 2026.
The BVMW surveyed more than 1,000 Mittelstand companies in an online poll conducted between December 18 and 23.
LATEST POSTS
- 1
What to know about the "wild, wild West" of viral peptide claims - 2
Safeguarding Your Senior Protection Against Extortion and Tricks. - 3
Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer - 4
Five held on suspicion of planning attack on German Christmas market - 5
The Green Transformation: 5 Feasible Living Practices
Top 20 Wellbeing and Wellness Applications for a Sound Way of life
Hezbollah fires over 600 times at Israel, IDF troops over last 24 hours
Plans for ‘stop anywhere’ night buses recommended by government for women’s safety
RSF attack on Sudan’s South Kordofan kills at least 14, including children
Kenmore East reacts to their best overall delegation award at WNY Model United Nations General Assembly competition
Foot fossil discovery could reshape human evolutionary history
Blue Origin safely launches wheelchair user to space and back
Hidden Island Cameras Capture Rare Tasmanian Species for the First Time Ever
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says












